Fundraising Fox

Evoendo

Centennial, US · Founded 2017 · United States corporation · 1 known investors

evoendo.com ↗

EvoEndo develops FDA-cleared endoscopy systems that enable sedation-free transnasal and transoral procedures for patients of all ages. The company manufactures ultra-thin, flexible scopes with advanced imaging and patient distraction technology to reduce risk and improve accessibility in upper gastrointestinal diagnostics.

HealthtechMedical Devicesin /evoendo

Founders & leadership

JFJoel Friedlander
Joel FriedlanderinExecutive Officer, Director
JH
Jonathan HartmannExecutive Officer, Director
RHRyan Hartman
Ryan HartmaninExecutive Officer
EDEmily DeBoer
Emily DeBoerDirector
RDRobin Deterding
Robin DeterdingVice President and Director
JPJeremy Prager
Jeremy PragerDirector
BLBetsy Lahue
Betsy LahueDirector
DB
David BunningDirector
CRChris Rowland
Chris RowlandDirector
JHJeff Harrington
Jeff HarringtonDirector
CTCarl Traynor
Carl TraynorDirector
DPDavid Pierce
David PierceDirector

Investors · 1

Allerfund Ventures, LlcNew York

Reported raises · per SEC filings

Form D private placements
▶$2.3MraisedAug 2024 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Betsy LahueDirector
  • David BunningDirector
  • Chris RowlandDirector
  • Jeff HarringtonDirector
  • Joel FriedlanderExecutive Officer, Director
  • Jonathan HartmannExecutive Officer, Director
  • Carl TraynorDirector
  • David PierceDirector
  • Ryan HartmanExecutive Officer
Offering amount
$3M
Amount sold
$2.3M
First sale
Aug 2024
Incorporated
Corporation, United States
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedDec 2019 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff HarringtonDirector
  • Jeremy PragerDirector
  • Robin DeterdingExecutive Officer, Director
  • Joel FriedlanderExecutive Officer, Director
  • Emily DeBoerDirector
Offering amount
$2.5M
Amount sold
$1.9M
First sale
Dec 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedMar 2018 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Emily DeBoerDirector
  • Robin DeterdingExecutive Officer, Director
  • Jeremy PragerDirector
  • Joel FriedlanderExecutive Officer, Director
Offering amount
$500K
Amount sold
$500K
Proceeds to insiders
$2.7K
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.